Consolidated Net Profit (Q2 FY26) ₹4.85 Cr ▲ 1,632.14% YoY Revenue Growth (Q2 FY26) ₹15.57 Cr ▲ 94.62% YoY Operating…
Read More

Consolidated Net Profit (Q2 FY26) ₹4.85 Cr ▲ 1,632.14% YoY Revenue Growth (Q2 FY26) ₹15.57 Cr ▲ 94.62% YoY Operating…
Read More
Net Profit (Q3 FY26) ₹9.28 Cr ▲ Returned to profit Revenue Growth (YoY) +66.64% ₹90.45 Cr in Q3 Operating Margin…
Read More
The company’s stock has struggled significantly, declining 16.03% over the past year whilst the Sensex gained 6.49%, resulting in negative…
Read More
196 The grey skies over Brussels’ European quarter have long observed the annual ritual of fishing quota nereceivediations, a delicate…
Read More
India’s IPO wave displays rising promoter exits, inflated valuations, and retail investor risks as offers for sale dominate fresh capital…
Read More
With a market capitalisation of ₹3,743 crores and trading at ₹274.05 following a 9.12% single-day surge, Artemis Medicare commands a…
Read More
Net Profit (Q2 FY26) ₹2.24 Cr ▲ 8.21% YoY Net Sales (Q2 FY26) ₹26.85 Cr ▼ 4.82% YoY Operating Margin…
Read More
Net Profit (Q2 FY26) ₹158.04 Cr ▲ 151.18% YoY Revenue (Q2 FY26) ₹3,271.68 Cr ▲ 10.63% YoY Operating Margin 9.50%…
Read More
The stock, trading at ₹854.00 on October 31, 2025, has declined 2.26% in the latest session and remains under pressure,…
Read More